"Lyme Disease Vaccine Shows 70 Percent Efficacy, Pfizer Says"
"Four doses of an experimental vaccine to protect against Lyme disease reduced the number of tick-borne infections by more than 70 percent, according to Pfizer and Valneva, the pharmaceutical companies developing the shot." "If approved by regulators, it could become the only Lyme disease vaccine available for people — although it would not be the first."










